- Stocks
- Healthcare
- NYSE: NVTA

Price (delayed)

$0.5082

Market cap

$145.6M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$5.24

Enterprise value

$1.49B

itae Corporation is a leading medical genetics company whose mission is to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people. Invitae's goal is to

NVTA's gross margin is up by 42% year-on-year and by 24% since the previous quarter

NVTA's gross profit is up by 31% year-on-year and by 21% since the previous quarter

The net income has plunged by 80% from the previous quarter but it has soared by 55% YoY

NVTA's EPS has dropped by 70% since the previous quarter but it has surged by 62% year-on-year

NVTA's quick ratio has dropped by 64% year-on-year and by 21% since the previous quarter

The revenue has contracted by 7% YoY and by 2.5% from the previous quarter

What are the main financial stats of NVTA

Market
Valuations
Earnings

Shares outstanding

286.49M

Market cap

$145.6M

Enterprise value

$1.49B

Price to earnings (P/E)

N/A

Price to book (P/B)

N/A

Price to sales (P/S)

0.29

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

3.09

Revenue

$481.58M

EBIT

-$1.42B

EBITDA

-$1.27B

Free cash flow

-$247.49M

Per share
Balance sheet
Liquidity

EPS

-$5.24

Free cash flow per share

-$0.9

Book value per share

-$4.06

Revenue per share

$1.75

TBVPS

$1.94

Total assets

$535.12M

Total liabilities

$1.62B

Debt

$1.51B

Equity

-$1.08B

Working capital

$219.98M

Debt to equity

-1.39

Current ratio

2.39

Quick ratio

2.19

Net debt/EBITDA

-1.06

Margins
Efficiency
Dividend

EBITDA margin

-262.8%

Gross margin

27.1%

Net margin

-299.1%

Operating margin

-306.7%

Return on assets

-101%

Return on equity

N/A

Return on invested capital

-72.2%

Return on capital employed

-375.9%

Return on sales

-294%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the Invitae stock price performed over time

Intraday

-1.78%

1 week

-6.43%

1 month

-16.41%

1 year

-82.89%

YTD

-72.68%

QTD

-16.03%

How have Invitae's revenue and profit performed over time

Revenue

$481.58M

Gross profit

$130.64M

Operating income

-$1.48B

Net income

-$1.44B

Gross margin

27.1%

Net margin

-299.1%

The company's operating margin has shrunk by 93% QoQ but it has surged by 51% YoY

The operating income has dropped by 88% since the previous quarter but it has soared by 54% year-on-year

NVTA's net margin has dropped by 85% since the previous quarter but it has surged by 52% year-on-year

The net income has plunged by 80% from the previous quarter but it has soared by 55% YoY

What is Invitae's growth rate over time

What is Invitae stock price valuation

P/E

N/A

P/B

N/A

P/S

0.29

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

3.09

NVTA's EPS has dropped by 70% since the previous quarter but it has surged by 62% year-on-year

The stock's P/S is 97% less than its 5-year quarterly average of 9.1 and 52% less than its last 4 quarters average of 0.6

The revenue has contracted by 7% YoY and by 2.5% from the previous quarter

How efficient is Invitae business performance

The company's return on assets has shrunk by 127% QoQ and by 10% YoY

NVTA's ROIC has plunged by 102% from the previous quarter but it is up by 46% YoY

NVTA's return on sales has dropped by 91% since the previous quarter but it has surged by 52% year-on-year

What is NVTA's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for NVTA.

How did Invitae financials performed over time

Invitae's total assets is 67% lower than its total liabilities

Invitae's total assets has shrunk by 74% YoY and by 65% QoQ

NVTA's quick ratio has dropped by 64% year-on-year and by 21% since the previous quarter

NVTA's debt to equity has dropped by 113% year-on-year but it has surged by 82% since the previous quarter

NVTA's debt is down by 14% year-on-year and by 4.7% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.